Skip to main content

Table 2 Periodic changes in pathomorphologic findings from fundus

From: Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema

 

Observation group

IVD-treated group

p-value

Mean

SD

Mean

SD

Vascular tortuosity (μm/μm)

 Superior

  Baseline

0.24

0.14

0.34

0.20

0.78*

  1 month

0.24

0.09

0.25

0.06

0.90*

  3 months

0.21

0.08

0.20

0.07

0.98*

  6 months

0.19

0.07

0.18

0.07

0.87*

  12 months

0.18

0.05

0.17

0.07

0.89*

  p-value

0.094

 

0.025

 

0.014

 Inferior

  Baseline

0.50

0.15

0.67

0.45

0.13*

  1 month

0.46

0.18

0.40

0.31

0.26*

  3 months

0.38

0.13

0.30

0.24

0.15*

  6 months

0.34

0.12

0.30

0.30

0.59*

  12 months

0.33

0.15

0.18

0.13

0.14*

  p-value

0.059

 

0.002

 

0.036

Vascular width (μm)

 Superior

  Baseline

297.28

69.87

310.13

79.89

0.12*

  1 month

288.45

68.61

266.94

71.33

0.020*

  3 months

273.33

54.78

262.47

55.37

0.13*

  6 months

270.71

47.81

252.53

51.64

0.39*

  12 months

238.37

70.56

245.03

58.82

0.48*

  p-value

0.014

 

0.007

 

0.024

 Inferior

  Baseline

285.30

68.63

295.05

88.79

0.13*

  1 month

288.85

47.55

258.60

59.37

0.012*

  3 months

250.22

49.02

236.21

50.38

0.062*

  6 months

248.00

37.73

216.44

69.29

0.26*

  12 months

227.01

49.21

213.20

48.21

0.22*

  p-value

0.11

 

0.001

 

0.003

Retinal hemorrhage (score)

 Baseline

20.60

15.38

27.70

9.70

0.052*

 1 month

19.62

11.63

12.50

10.30

0.20*

 3 months

12.22

8.52

8.01

9.00

0.062*

 6 months

11.20

8.24

7.40

5.86

0.18*

 12 months

8.24

4.75

3.16

4.88

0.062*

p-value

0.010

 

< 0.001

 

0.006

Cotton wool spots (number)

 Baseline

3.75

2.79

3.89

3.28

0.24*

 1 month

2.75

2.10

2.11

3.10

0.67*

 3 months

2.33

0.22

2.03

0.15

0.66*

 6 months

2.12

0.38

2.01

0.34

0.74*

 12 months

1.18

0.40

1.22

0.60

0.76*

p-value

0.004

 

0.002

 

0.42

  1. Analysis used *Mann-Whitney U test to compare groups at each time-point; Wilcoxon signed-rank test to compare baseline and endpoints within a group; and generalized estimating equation to compare changes with time between the groups
  2. IVD intravitreal dexamethasone
  3. The bold font for P-values indicates a statistical significance (i.e., P < .05)